Feasibility study of clinical sequence in multiple myeloma and related Diseases; Additional study of JSH-MM-15 (JSH-MM-15-Cseq)

Feasibility study of clinical sequence in multiple myeloma and related Diseases; Additional study of JSH-MM-15 (JSH-MM-15-Cseq) - Study of clinical sequence in multiple myeloma; JSH-MM-15-Cseq

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029879

Enrollment

Registered

2017-11-08

Start date

2017-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma and related disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) A case enrolled in the JSH-MM-15 study(Prospective observational study to assess the prognosis of patients with plasma cell neoplasms in Japan) 2) diagnosed as having plasma cell neoplasms including symptomatic myeloma, non-secretary myeloma, multiple plasmacytoma of bone, and plasame cell leukemia 3) A case with sufficient tumor and non-tumor samples for the genomic analysis 4) A subject with written informed consent

Exclusion criteria

Exclusion criteria: A subject considered as an inappropriate participant for the current study

Design outcomes

Primary

Measure	Time frame
Ratio of potentially actionable findings(PAF), used as a feedback to the attending physician	—

Countries

Japan

Contacts

Public ContactMasaki Ri

Nagoya City University Graduate School of Medical Sciences Hematology and Oncology

rrmasaki@med.nagoya-cu.ac.jp052-853-8738

Outcome results